Autopsy report · NCT02354417
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies
Cause of deathNo reason given
Life of this trial
- Registered 3 months before it started.
- Ran for about 2 years 2 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 1 year 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Fate Therapeutics
- Sponsor type
- Industry
- Conditions
- Hematologic Malignancies
- Interventions
- Biological: ProHema-CB
- Participants
- 3
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.